Same handle on other site. Vice President, Biology @10xgenomics. Former @nygctech/@nygenome. Views my own 🇦🇺

Joined December 2014
3 Photos and videos
Peter Smibert retweeted
We’re excited to announce our acquisition of Proteintech Genomics, a division within Proteintech Group, expanding our capabilities in proteomics and supporting our vision for integrated multiomic analysis across single cell and spatial biology. Learn more: bit.ly/49R7zTz
2
13
41
6,212
Peter Smibert retweeted
I'm really thrilled to share what I've been working on the past year! We hope this method represents a step towards democratizing single-cell screens, and helps to make it possible to run genome-wide scale experiments routinely. Check out our tweetorial and the preprint here 👇
Excited to share VIPerturb-seq! New tech from my lab which aims to improve the cost, data quality, and efficiency of single-cell CRISPR screens so that they are accessible to any lab - even at genome-wide scale Preprint and 🧵 (1/): biorxiv.org/content/10.64898…
7
30
4,389
Peter Smibert retweeted
Excited to share VIPerturb-seq! New tech from my lab which aims to improve the cost, data quality, and efficiency of single-cell CRISPR screens so that they are accessible to any lab - even at genome-wide scale Preprint and 🧵 (1/): biorxiv.org/content/10.64898…
5
84
317
25,608
Peter Smibert retweeted
And another one. ☝️ Last week: ProPer-seq. This week: VIPerturb-seq from the Satija Lab. Paper after paper is proving @10xGenomics Flex is the definitive engine for genome-scale perturbation screens. The new stats are wild: 🚀 440,000 cells per lane 🚀 50x throughput boost 🚀 65% more genes detected/cell Routine genome-scale screens are here. #singlecell #genomics #CRISPR #biotech #10xGenomics #virtualcell
1
1
9
1,174
Peter Smibert retweeted
We put a blog post together to tell you about all that went behind the scenes for @arcinstitute's Virtual Cell Challenge: (1) the modality used for genetic perturbations, (2) choice of single cell RNA seq chemistry, (3) which cell line to use for the challenge, (4) which genes to perturb, (5) the quality considerations for the resulting dataset, and (6) how we defined performance metrics for perturbation predictions.
10
33
180
26,581
Peter Smibert retweeted
Smaller studies? We’ve got you covered. New 8-sample #singlecell kits for Universal 3’ & 5’, plus lower prices: bit.ly/4fK417l
2
5
14
8,073
Peter Smibert retweeted
Excited to announce that we're becoming part of 10x Genomics! This acquisition will validate our team's incredible work and scales our impact in single cell innovation, bringing even greater value to our research community. Here's to the next phase! hubs.la/Q03BRN0B0
2
4
13
2,479
RT @GarryPNolan: Ideas aren’t just born fully mature into commercial realization. They require refinement, testing, well-integrated teams,…
23
Peter Smibert retweeted
This acquisition will bring together two pioneering companies with a shared vision: to make single cell analysis more powerful, affordable and accessible to researchers worldwide. Learn more: bit.ly/4mru4lK
15
33
44,285
Peter Smibert retweeted
New #singlecell benchmarking data is here! The team @HutchInnovation has been hard at work comparing the latest assays. Read the preprint for all the data and see how top-performing Flex and Universal assays can make a huge difference in your research: bit.ly/4569a6l
1
12
23
2,131
Peter Smibert retweeted
We are pleased to share our work evaluating some of the latest single-cell platforms, including updated chemistries, in two separate experiments using peripheral blood mononuclear cells (PBMCs). biorxiv.org/cgi/content/shor…

1
11
31
4,066
Peter Smibert retweeted
In collaboration with Reuben Saunders, @JswLab, and Xiaowei Zhuang, we are very excited to release Perturb-Multi: a platform for pooled multimodal genetic screens in intact mammalian tissue. Check it out! biorxiv.org/content/10.1101/…
2
111
335
169,396
Peter Smibert retweeted
One key component of Perturb-Multi is in vivo Perturb-seq of formaldehyde-fixed tissue, enabled by the Flex reagents from @10xGenomics.
In collaboration with Reuben Saunders, @JswLab, and Xiaowei Zhuang, we are very excited to release Perturb-Multi: a platform for pooled multimodal genetic screens in intact mammalian tissue. Check it out! biorxiv.org/content/10.1101/…
1
11
66
20,203
Peter Smibert retweeted
Comparison of Fixed Single Cell RNA-seq Methods to Enable Transcriptome Profiling of Neutrophils in Clinical Samples biorxiv.org/cgi/content/shor… #biorxiv_genomic

2
2
898
Peter Smibert retweeted
7 Jul 2024
doi.org/10.1038/s41587-023-0… @NatureBiotech Important benchmarking, code and #data from #PBMCs, across platforms. @10xGenomics does well Reassuringly consistent cell estimates of DARs (differentially accessible regions)
1
9
687
Tune in tomorrow to see @tsion_abay present her work on PERFF-seq, a novel method for enriching for specific cell types and states upstream of @10xGenomics' Flex assay. 10xgenomics.com/blog/from-ra…
13 Jun 2024
Join #ScienceWebinars for their next technology broadcast! Live on Tuesday, June 18 at 12 p.m. ET, tune into "Breaking barriers: Transcript-specific enrichment for profiling of rare cell states via single-cell RNA sequencing" Register today: brnw.ch/21wKISU
3
13
2,147
Peter Smibert retweeted
GoT-ChA! I am thrilled to announce that our paper "Mapping Genotypes to Chromatin Accessibility Profiles in Single Cells" is now out in @Nature !! 👩‍🔬👨‍🔬🧬If you want to link somatic mutations to epigenetic changes directly in patient samples: nature.com/articles/s41586-0… 👇🧵
23
99
434
46,200
Peter Smibert retweeted
#FixNCut, a method for early sample preservation to overcome current limitations in Single-cell omics | ⁦@cnag_eu⁩ ⁦@ACEpigenetics⁩ ⁦@UniofAdelaide⁩ ⁦@StJudeResearch⁩ ⁦@OmniscopeAI⁩ ⁦@SAiGENCI⁩ ⁦@PeterMacCCcnag.eu/news/fixncut-new-met…

1
11
47
5,699